Philip M Levesque

Title: The Innovations of Philip M. Levesque

Introduction

Philip M. Levesque is an accomplished inventor based in Wellesley, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. His work is characterized by a focus on stability and efficacy in therapeutic applications.

Latest Patents

Levesque holds a patent for a "Stable anti-OSMR antibody formulation." This invention provides stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody, with a pH ranging from approximately 6.0 to 7.6. Notably, less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation. This innovation is crucial for enhancing the therapeutic potential of antibodies in clinical settings.

Career Highlights

Philip M. Levesque is currently associated with Kiniksa Pharmaceuticals, Ltd., where he continues to advance his research and development efforts. His expertise in antibody formulation has positioned him as a key player in the biotechnology industry.

Collaborations

Levesque has worked alongside notable colleagues, including Mark Cornell Manning and Zahra Shahrokh. Their collaborative efforts contribute to the innovative environment at Kiniksa Pharmaceuticals.

Conclusion

Philip M. Levesque's contributions to the field of biotechnology, particularly through his patent for stable anti-OSMR antibody formulations, highlight his role as a significant inventor. His work continues to impact the development of effective therapeutic solutions.